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Members of the evolutionarily conserved T-box family of transcription factors are important players in developmental processes that
include mesoderm formation and patterning and organogenesis both in vertebrates and invertebrates. The importance of T-box genes
for human development is illustrated by the association between mutations in several of the 17 human family members and congenital
errors of morphogenesis that include cardiac, craniofacial, and limbmalformations.We identiﬁed two unrelated individuals with a com-
plex cranial, cervical, auricular, and skeletal malformation syndrome with scapular and pelvic hypoplasia (Cousin syndrome) that
recapitulates the dysmorphic phenotype seen in the Tbx15-deﬁcient mice, droopy ear. Both affected individuals were homozygous for
genomic TBX15 mutations that resulted in truncation of the protein and addition of a stretch of missense amino acids. Although the
mutant proteins had an intact T-box and were able to bind to their target DNA sequence in vitro, the missense amino acid sequence
directed them to early degradation, and cellular levels were markedly reduced. We conclude that Cousin syndrome is caused by
TBX15 insufﬁciency and is thus the human counterpart of the droopy ear mouse.We studied two unrelated girls of German (patient 1) and
Turkish (patient 2) ancestry. The girls shared an identical
phenotype consisting of short stature and macrocephaly.
Patient 1 had a birth length of 43 cm (2.4 standard devi-
ation [SD]) and head circumference of 38 cm (þ 0.83 SD)
and an adult height of 115 cm (8.18 SD) and a head
circumference of 61.5 cm (þ4.12 SD). Patient 2 at her
most recent follow-up at 10 years of age had a height of
105 cm (4.41 SD) and a head circumference of 53 cm
(50th percentile). Their dysmorphic features included fron-
tal bossing, narrow palpebral ﬁssures with deep set globes
and hypertelorism, strabismus, low-set ears with posterior
rotation and dysplasia of the conchae, narrow auditory
canals and hypoacusis, a short neck with redundant skin-
folds, and a low hairline (Figure 1). The habitus of both
girls was characterized by macrocephaly, ﬁxed ﬂexion at
the elbow joints, a short neck, and leg shortening caused
by bilateral dislocation of the hips and hip ﬂexion. The
main radiographic features were hypoplastic scapulae
and iliac bones, short femurs, humeroradial synostosis,
and moderate brachydactyly. In addition, the skull base
was abnormally shaped, resulting in markedly low attach-
ment of the ears and in caudal displacement of the occip-
ital bone (Figure 2). Both girls had normal intelligence and
attended normal school (at age 12 years; patient 2) or col-
lege (at age 19 years; patient 1). Both parent couples were
consanguineous (second and ﬁrst cousins, respectively)
and showed none of the clinical and radiographic signs
seen in their daughters. Patient 1 had been given a diagno-The Americasis of campomelic dysplasia (MIM 114290) because of scap-
ular and iliac hypoplasia; patient 2 had been diagnosed
with Kosenow scapuloiliac dysostosis (MIM 169550). How-
ever, their phenotype did not ﬁt either campomelic dyspla-
sia or Kosenow scapuloiliac dysostosis; sequence analysis
of the SOX9 gene (MIM 608160) was normal. We found
that the dysmorphic pattern in these girls corresponded
closely to a condition described by Cousin et al. in 19821
as ‘‘Dysplasie pelvi-scapulaire familiale avec anomalies e´piphis-
aires, nanisme, et dysmorphies’’ (familial pelvis-scapular
dysplasia with epiphyseal anomalies, dwarﬁsm, and
dysmorphisms; listed in OMIM as Cousin syndrome or
pelviscapular dysplasia; MIM 260660). Cousin syndrome
has not been reported again since the original description,
although some patients reported as having Kosenow
syndrome may in fact have had Cousin syndrome.2
Guided by the ﬁndings of scapular hypoplasia and abnor-
mal cranio-facio-cervical morphology, we identiﬁed the
Tbx15-deﬁcient mouse phenotype as a possible homolog
to Cousin syndrome. Murine Tbx15 deﬁciency occurs as
the result of a deletion involving several exons of Tbx15
in the spontaneous mouse mutant, droopy ear (de)3, and
has been reproduced by targeted disruption of the gene.4,5
First described in1959,droopy ear exhibits a complexcranio-
facial malformation including small, widely spaced eyes
with short palpebral ﬁssures, a broadnasal area, a shortened
skull held in an elevated position, misshapen and rotated
external ears, and an abnormal coat-color patterning.3,6
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small overall size, hypoplastic scapulae, moderate shorten-
ing of several long bones, and a dysmorphogenesis of
cranial bones and cervical vertebrae, including vertical dis-
placement of the supraoccipital bone, a small basiooccipital
bone, a small foramen magnum, and changes in the shape
of the squamosum and of the ﬁrst and second vertebrae.4,5
These changes were reminiscent of those observed in the
two patients studied.
Peripheral bloodDNAwasobtainedwithappropriate fully
informed consent from the two individuals with Cousin
syndrome and from their parents. Human studies were ap-
Figure 1. Clinical Features of the Two
Girls with Cousin Syndrome and TBX15
Mutations
Patient 1 is age 5 yr in (A) and (B) and age 3
yr in (C); patient 2 is age 10 yr in (D), (E),
and (F). The main features are bossing, ma-
lar hypoplasia, and a small chin; narrow pal-
pebral fissures; a short neck with redundant
skinfolds; low-set, posteriorly rotated, and
dysplastic external ears; apparent femoral
shortening because of femoral head dislo-
cation; and short stature.
Figure 2. Radiographic Findings in Cousin Syndrome
(A, C, and E) Patient 1. (B, D and F) Patient 2. Skeletal features
seen in the two patients include aplasia of the blade of the scapula,
humeroradial synostosis, marked hypoplasia of the iliac bones, and
dislocation of the femoral heads. (G) A sagittal section of a cranial
MRI of a normal woman aged 19 years. (H) A corresponding section
from patient 2 at age 12 years. From the tip of the odontoid process
in the center of each panel, the arrows extend anteriorly to the
frontal bone and posteriorly to the posterior margin of the foramen
magnum. Caudal displacement of the occipital bone is evident in
the patient; note also the redundant skin fold over the posterior
aspect of the neck. The cranial and skeletal features are remarkably
similar to those seen in Tbx15-ablated mice.5
proved by the ethical review boards
of the two hospitals (Freiburg and An-
kara). The TBX15 genomic sequences
were determined with PCR ampliﬁca-
tions of individual exons by standard
methods; primer sequences were designed with the TBX15
genomic sequences available at Ensembl (see Web Re-
sources; accessionnumber ENSG00000092607).We studied
the consequences of the mutatons by inserting the muta-
tions into TBX15 expression vectors. TBX15 was ampliﬁed
from normal human ﬁbroblast cDNA, oligonucleotides
were based on transcript ENST00000207157 (TBX15S, 496
amino acids), and transcript ENST00000369429 (TBX15L,
602 amino acids). PCR products were inserted into pCRII-
TOPO (Invitrogen), the disease-associated mutations
TBX15-1042 delA, TBX15-1044 delA, and the deletion mu-
tant TBX15-DC (amino acids 1–344, stop codon at base
pair 1045) were introduced by site-directed mutagenesis.
Wild-type and mutated ORFs were fully sequence veriﬁed
and subcloned into pBABE-puro,7 pBABE-EGFP,8 and
pCDNA3 (Invitrogen). N-terminal tags for the FLAG
(pBABE), EGFP (pBABE), and the Myc epitope (pCDNA3,
pSP64) were fused in frame by PCR or subcloning. For
in vitro expression, TBX15 cDNAs were subcloned in the
vector pSP64 (Promega) that was modiﬁed to contain a 50
b-globin leader and a 30 b-globin trailer, suitable for the
TNTSP6High-Yield Protein Expression System (Promega).
We performed the electrophoretic mobility shift assay
(EMSA) as described9 to test the DNA binding ability of650 The American Journal of Human Genetics 83, 649–655, November 7, 2008
Figure 3. Genomic TBX15 Mutations
(A) The genomic TBX15 sequences in patient 1, patient 2, the mother of patient 2, and a control. Patient 1 is homozygous for c.1042 delA,
and patient 2 is homozygous for c.1044 delA in the same codon. (B) The TBX15 mRNA levels in an age-matched control and patients’
fibroblasts of the same passage by semiquantitative RT-PCR; expression of the mutant alleles was verified by cDNA sequencing. (C) A
schematic representation of the two physiological transcripts of the TBX15 protein (differing in the start codon) as well as of the two
predicted mutant ORFs; in the mutant proteins, the normal amino acid sequence is interrupted after amino acid 449 or 450 and is followed
by a stretch of 78 or 77 missense amino acids. The DNA-binding T-box is preserved in both mutant variants.mutant TBX15 protein. Oligonucleotides used to generate
binding sites were BS.dirF 50-GATCCGGAGGTGTGAAG
GTGTGAAAGGA-30 and BS.dirR 50-GATCTCCTTTCACACC
TTCACACCTCCG-30. Cell culture, gene transfer, and ex-
pression analysis were performed as described.8,9 High-titer
retroviral gene transfer via BING packaging cells10 was used
for transduction of human chondrosarcoma (HCS, ATCC)
andhumanﬁbrosarcoma cells (HT1080, ATCC).Viral super-
natants were titered prior to infection to give anMOI (mul-
tiplicity of infection) of 10 for each construct. Transduced
cell populations were analyzed either 48 hr after infection
or after selection with 5 mg/ml puromycin for 72 hr.
Whole-cell lysates and subcellular protein fractionswereob-
tained 48 hr after transfection by lysis in 13 SDS sample
buffer or by hypotonic lysis,8 followed by soniﬁcation and
immunoblot analysis. Patients’ ﬁbroblasts derived from
skin biopsies were expanded to passage ﬁve; RIPA buffer
was used for extracting proteins for immunoblot analysis.
Antibodies included anti-FLAGM5 (Sigma), anti-GFP (Santa
Cruz), anti-b-actin (Sigma), and a polyclonal serum gener-
ated by immunization of rabbits with a GST fusion protein
containing the amino acids 1–300 of TBX15. For direct ﬂuo-
rescent detection of EGFP fusion proteins, cells were cul-
tured on chamber slides, ﬁxed in 4% paraformaldehyde forThe America10 min at room temperature, washed thrice with PBS, and
counterstained with DAPI antifade (Q Biogene). Images
were captured with a Leica (DMRXA) microscope with
a cooledCCD(Sensys Photometrics). Forproteasome inhibi-
tion, MG-132 (Sigma) was added to the culture medium at
25 mM prior to the collection of cell lysates.
To test the possible homology between Cousin syn-
drome and the mouse Tbx15 deﬁciency, we obtained
DNA from the two individuals with Cousin syndrome
and their parents after having obtained informed consent
and then searched directly for TBX15 genomic sequence
variations (primer information and PCR conditions are
available upon request). We identiﬁed two different
single-nucleotide deletions that segregated in each family
and were homozygous in the affected girls, heterozygous
in their parents, and absent in a panel of over 216 control
chromosomes. Both deletions occurred at codon 344; in
family 1, deletion of adenosine 1042 (c.1042 delA at the
ﬁrst position within codon 344) led to a frame shift with
78 missense amino acids followed by a stop codon; in fam-
ily 2, the deletion occurred at the third position of the
same codon (c.1044 delA) an led to 77 missense amino
acids and the stop codon (Figure 3A); both missense
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predicted the abolition of the C-terminal 152 amino acids
of the principal short and long isoforms of the mature
TBX15 protein (Figure 3C; for the reference sequence of
TBX15 isoforms, see Web Resources). Semiquantitative
PCR and sequencing of cDNA isolated from patients’ and
controls’ ﬁbroblasts showed that the mutant mRNA was
expressed at a level that was the same as or higher than
that of wild-type mRNA (Figure 3B).
We then investigatedwhether themutations affected the
ability ofmutantTBX15protein tobind their targetDNAse-
quences in anEMSAafter incubationof invitro-synthesized
wild-type and mutant TBX15 proteins (Figure 4B) with oli-
gonucleotides corresponding to the mouse Tbx15 target
DNA sequence that was identiﬁed previously9 (Figure 4A).
Target DNA binding of the mutant proteins was similar
to that of wild-type protein (Figure 4C), in keeping with
the notion that the DNA-binding region of the protein,
the T-box, was unaffected by the mutations.
Given that theDNA-bindingabilityof themutantproteins
was conserved, we then focused on the localization and sta-
bility ofmutant TBX15proteins. Immunoblot analysis of cy-
toplasmic and nuclear extracts of patients’ ﬁbroblasts with
antiserum raised against the amino terminal part of the
long isoform of TBX15 (TBX15L) showed an almost com-
plete lossof theTBX15Lsignal in thepatients,whereasbands
of the expected size were detected in the nuclear fraction of
both age-matched controls (Figure 5A). For further studies,
the wild-type and mutant cDNA sequences were cloned
Figure 4. In Vitro DNA Binding Analysis
of Mutant TBX15 Proteins
(A) The previously identified7 binding site
of mouse Tbx15 (BSdir) that was tested in
EMSAs. Arrows indicate the orientation of
T-half sites. (B) Assays were performed
with equal amounts of in vitro-synthesized
Myc-tagged TBX15 proteins, as determined
by anti-Myc immunoblot. All proteins were
expressed with the expected molecular
weights. (C) No differences in DNA binding
to the site BSdir are observed between the
C-terminally truncated form TBX15-del
C-term protein and the wild-type form of
TBX15 or the c.1042 delA and c.1044 delA
mutants in a gel-shift assay. Equally strong
complexes were detected for all proteins (as-
terisks). Specificity of bindingwas confirmed
by addition of anti-Myc antibody, which
resulted in the formation of a prominent
supershifted complex (black arrowhead).
into expression vectors. Figure 5B
shows expression of FLAG-tagged
TBX15proteins inhuman chondrosar-
coma (HCS) cells. The wild-type pro-
teinwas readily detectable and showed
the expected predominantly nuclear
localization; no TBX15 protein was
detected after transduction with either of the two mutants,
in spite of adequate mRNA levels (data not shown). When
EGFP-tagged TBX15 protein isoforms were analyzed by
direct ﬂuorescence microscopy, the wild-type protein gave
a strong signal in both the cytoplasm and the nucleus (short
isoform, Figure 6B) or exclusively in the nucleus (long iso-
form, Figure 6A); themutant constructs gave a barely detect-
able signal, indicating that protein stability was compro-
mised. Similar results were obtained when Myc-tagged
TBX15 proteins and anti-Myc immunoﬂuorescence detec-
tion were used in HeLa and HEK293 cells (data not shown).
To elucidate themechanisms leading to instability of the
mutant proteins, we transfected HeLa cells with wild-type
human TBX15, the two mutants identiﬁed in the Cousin
syndrome patients, or a synthetic mutant harboring the
truncation of the protein after amino acid residue 344. Cel-
lular levels of theC-truncated proteinwere similar to that of
the wild-type, whereas levels of the two human mutants
were signiﬁcantly reduced; these could be partially restored
by addition of the proteasome inhibitor, MG-132 (Fig-
ure 5D). Thus, simple truncation of 152 amino acids at
the C terminus did not affect stability, but the presence of
the 78 (versus 77) missense amino acids in the mutants
directed the TBX15 protein to proteasomal degradation.
To conﬁrm this interpretation, we generated constructs in
whichEGFPwas fuseddirectlyonto either thewild-type car-
boxy-terminal portionof TBX15or the two stretches ofmis-
sense amino acids predicted by the human mutations.652 The American Journal of Human Genetics 83, 649–655, November 7, 2008
Figure 5. Immunoblot Analysis of TBX15 Protein in Patients’ Fibroblasts and in Cell Transfection Experiments
(A) Analysis of TBX15 proteins in subcellular fractions (C ¼ cytoplasmic extract, N ¼ nuclear extract) of patients’ and control fibroblasts.
A polyclonal antiserum directed against the amino-terminus of the long isoform of TBX15 (TBX15L) was used for the immunoblots, which
show a strong reduction of the signal for the long isoform of TBX15 in both patients. The nature of the band that has an apparent
molecular weight of approximately 50 kDa and migrates below TBX15L is unclear but may be due to cross-reactivity of the antiserum
with the related protein TBX18. Membranes were reprobed with an antibody against b-actin so that equal loading could be ensured.
(B) Disease-associated mutations confer instability to transgenic TBX15. Analysis of TBX15 proteins in subcellular fractions (C ¼ cyto-
plasmic extract, N ¼ nuclear extract) of human chondrosarcoma (HCS) cells overexpressing either FLAG-tagged wild-type short variant
TBX15 or analogous constructs carrying the disease-associated mutations. An anti-FLAG immunoblot shows the presence of the wild-type
recombinant protein only.
(C) Disease-associated mutations confer instability to all isoforms of TBX15 and other proteins. Analysis of TBX15 proteins in human
chondrosarcoma (HCS) cells overexpressing either EGFP-tagged wild-type TBX15 or constructs carrying the disease-associated mutations
is shown. In addition, EGFP was fused directly to either the wild-type C-terminal portion of TBX15 (152 amino acids) or to the two
stretches of 78 or 77 missense amino acids predicted by the human mutations. Whole-cell lysates were analyzed by anti-GFP immunoblot.
Only lanes loaded with the wild-type fusion constructs gave a signal of the expected size.
(D) The C-terminal sequences resulting from disease-associated TBX15 mutations confer instability by directing proteins to proteosomal
degradation. Protein analysis of Myc-tagged wild-type TBX15, c.1042 delA, c.1044 delA, and DC proteins in HeLa cells probed in an anti-
Myc immunoblot. Expression of TBX15 mutants c.1042 delA and c.1044 delA is strongly reduced in comparison to that of the TBX15-wt and
Tbx15DC proteins (asterisks), indicating that the missense amino acids, and not the truncation, affect protein stability. Incubation with
the proteasome inhibitor MG-132 (25 mM) leads to a marked stabilization of TBX15-c.1042 delA, and c.1044 delA proteins. No more slowly
migrating bands that could represent poly-ubiquitinylated proteins were observed.Immunoblot analysis showed a strong signal for the wild-
typeC terminus, but the twomutantC terminiwere not de-
tectable (Figure 5C). Upon direct ﬂuorescence microscopy,
a signal was detected with the constructs containing the
wild-type but not the mutant isoforms of TBX15 (Figures
6A and 6B). When the constructs consisting of EGFP and
the C-terminal portions only were analyzed, ﬂuorescence
was detected with the constructs containing the wild-type
C terminus but not with the constructs containing themu-
tant C termini, conﬁrming that the stretches of missenseThe Americaamino acids produced by the frameshift mutation con-
ferred instability to the EGFP protein (Figure 6C).
In summary, genomic sequencing indicated that two
similar mutations segregated in the two families; these
mutations predicted the synthesis of TBX15 protein that
had an intact T-box but lacked a signiﬁcant portion of
the C-terminal region and had instead a stretch of 78 (or
77) missense amino acids that included ﬁve cysteine resi-
dues. The subsequent set of experiments indicated that al-
though TBX15 protein synthesized from the two mutantn Journal of Human Genetics 83, 649–655, November 7, 2008 653
Figure 6. Fluorescence Studies of EGFP-Tagged TBX15 Constructs
Intracellular localization of EGFP-tagged TBX15 proteins in HCS cells as detected by direct EGFP fluorescence microscopy. The TBX15 pro-
tein localizes exclusively (long variant [A]) or predominantly to the nucleus (short variant [B]; compare nuclear staining with DAPI),
whereas TBX15-c.1042 delA and c.1044 delA are barely detectable, both in the context of the long and of the short variant. A similar
loss of fluorescent signal was observed when the C terminus of the disease-associated protein variants was fused to EGFP (C). HCS cells
were transduced with titered recombinant virus at the same MOI for all constructs. Scale bars represent 15 (A and B) or 25 (C) mm.alleles retained the ability to bind their DNA targets
in vitro, cellular levels of TBX15 were drastically reduced
or abolished because of proteasome-associated degradation
directed by the C-terminal missense stretch. A similar
mutation in the TNSALP gene (MIM 171760), causing
the addition of a stretch of 80missense amino acids includ-
ing four cysteine residues, has been shown to cause protea-
somal degradation of the mutant alkaline phosphatase
protein and to result in severe hypophosphatasia (MIM
241500)11. Thus, the two affected subjects were homozy-
gous for mutations that resulted in functional TBX15
deﬁciency, conﬁrming the initial hypothesis of a shared
molecular basis for the changes seen in the craniocervical
bones, the scapula, and the pelvis in the subjects with
Cousin syndrome and in Tbx15-deﬁcient mice.
T-box genes encode a family of transcription factors that
regulate a variety of developmental processes in metazoa
ranging from hydra to humans. Mammalian genomes are
known to harbor 17 family members involved in pattern-
ing and differentiation processes during gastrulation and
organogenesis. Notably, mutations in human TBX genes,
TBX1, TBX3, TBX4, TBX5, TBX19(TPIT), TBX20, and
TBX22, are known to cause congenital disorders with
craniofacial, endocrine, limb, and cardiac malforma-
tion.12–19 The identiﬁcation of Cousin syndrome as
a TBX15-related disorder in humans further underscores
the importance of the T-box gene family for human devel-
opment and disease and adds an important piece to the
mosaic of our understanding of human genetic anomalies
of the skeleton.20 It also allows for molecular diagnosis and
genetic counseling; in fact, prior to our studies, the two
families reported here had been given other diagnoses
and had been counseled for dominant inheritance.
Tbx15 is known to be required for the condensation of
mesenchymal precursor cells in early development of the654 The American Journal of Human Genetics 83, 649–655, Novembskeleton.4,5,21 In themouse embryo,Tbx15 is expressed ﬁrst
in mesenchyme of the limb buds and subsequently in the
developing zeugopodal elements. In the cranium, expres-
sion begins in the mesenchyme near the surface ectoderm
and then can be detected in various craniofacial elements
that include themandibular process of the ﬁrst mandibular
arch and the dorsal edge of the hyomandibular cleft, which
will eventually become the external auditory meatus; the
surface of the second branchial arch as well as themaxillary
and themandibular portions of the ﬁrst branchial arch sur-
rounding the developingmouth; and the area that is dorsal
to each optic prominence and that later extends to sur-
round most of the eye.4,5,21 No expression is seen in inter-
nal organs between embryonic days 8.5 and 12.5, whereas
data fromEST libraries suggest an expression in adult tissues
of bone, brain, intestine, liver, muscle, testis, and thymus.
Although no expression data in the human are available,
the mouse expression pattern ﬁts reasonably well with
the phenotype observed in Cousin syndrome.
The target genes of TBX15 and of its closely related family
memberTBX18 (MIM604613)have remained elusive so far.
Scapular and pelvic hypoplasia are features of campomelic
dysplasia (MIM 114290) caused by SOX9 (MIM 608160)
mutations; scapular hypoplasia with humeroradial synos-
tosis is a feature of Antley-Bixler syndrome (MIM 207410,
201750) associated with mutations in either FGFR2 or
POR; the phenotypic relationship suggests that TBX15
may act within this contextual frame and/or share target
genes with SOX9, FGFR2 (MIM 176943), and POR (MIM
124015). Kosenow syndrome (scapuloiliac dysostosis,
MIM 169550) is a dominantly inherited condition with
hypoplasia of the scapula and pelvis but no craniocervical
malformation; its molecular basis is unknown. If Cousin
syndrome is caused by homozygosity for recessive TBX15
null mutations, there may be a phenotype associated wither 7, 2008
dominant mutations within the T-box region, and Kose-
now syndrome would be a possible candidate.
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Web Resources
The URLs for data presented herein are as follows:
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim/
Ensembl Human Gene View, www.ensembl.org; for human
TBX15, see
www.ensembl.org/Homo_sapiens/geneview?gene ¼ ENSG000000
92607; the short isoform (TBX15S; 496 amino acids) corre-
sponds to transcript ENST00000207157, and the long isoform
(TBX15L; 602 amino acids) corresponds to transcript ENST
00000369429.
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